Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of advanced cancers, today announces it has ...
3d
Arvinas Highlights Growing Phase 1 Pipeline, Near-Term Catalysts at TD Cowen Healthcare Conference
Executives from Arvinas (NASDAQ:ARVN) outlined recent pipeline progress and upcoming catalysts at TD Cowen’s 46th Annual Healthcare Conference, highlighting a growing set of Phase 1 programs built on ...
Mutations in the gene encoding LRRK2 (aka tyrosine kinase leucine-rich repeat kinase 2) are the most common cause of hereditary Parkinson disease. LRRK2 was discovered in 2004, and five years later it ...
Attempts to discern how mutations in the LRRK2 gene contribute to Parkinson’s disease have focused largely on the protein’s role as a kinase. In the January 8 Journal of Neuroscience, researchers led ...
An enzyme closely associated with genetic forms of Parkinson’s disease appears to play a larger role in its progression than previously thought, say investigators. The new research offers encouraging ...
Brad Paisley and Michael J. Fox play together at the Fox Foundation's 2017 "A Funny Thing Happened On The Way To Cure Parkinson's" fundraiser. Today, at a medical conference being hosted by the ...
LRRK2 mutations account for 5–13% of familial PD and 1–5% of sporadic PD. 6, 10 Therefore, LRRK2 mutation is the most common genetic cause of both familial and sporadic PD cases. PD-associated ...
Parkinson disease (PD) is the second most common neurodegenerative disorder and lacks disease-modifying treatments. A new study presents data from early-stage clinical trials of DNL201, an inhibitor ...
Future Neurology. 2012;7(2):145-153. Taken together, the present studies do not support a direct biochemical interaction between α-syn and LRRK2, or direct phosphorylation of α-syn by LRRK2, which ...
Biogen and Denali Therapeutics have begun dosing the first participants in a phase 3 study to evaluate the efficacy and safety profile of BIIB122 (DNL151) in approximately 400 patients with ...
An elusive protein that many consider the key of fully understanding the causes of genetic Parkinson's disease has come much more clearly into focus. Impacting millions around the world, Parkinson's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results